• Profile
Close

A pilot study of oral tranexamic acid and Glycyrrhizin compound in the treatment of recalcitrant Riehl’s melanosis

Journal of Cosmetic Dermatology Dec 07, 2018

Xu Z, et al. - Experts assessed the effectiveness and safety of a novel combination therapy with oral administration of tranexamic acid (TA) and Glycyrrhizin compound for recalcitrant Riehl’s melanosis. Findings suggested the probability of oral administration of TA in combination with Glycyrrhizin compound to be an effective therapy for Asian patients with recalcitrant Riehl’s melanosis. Compared with baselines, both mean MI and EI were significantly decreased. Moreover, the improvement of pigmentation and erythema with decreased pigment granules and telangiectatic vessels was confirmed by reflectance confocal microscopy (RCM) and dermatoscopy analyses.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay